Xtant Medical Holdings (FRA:XMS) Effective Interest Rate on Debt % : 13.89% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Xtant Medical Holdings's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was €3.00 Mil. Xtant Medical Holdings's average total debt for the quarter that ended in Dec. 2023 was €21.59 Mil. Therefore, Xtant Medical Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 13.89%.

Xtant Medical Holdings Effective Interest Rate on Debt % Historical Data

The historical data trend for Xtant Medical Holdings's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Effective Interest Rate on Debt % Chart

Xtant Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

7.43

11.43

5.84

10.30

14.28

Xtant Medical Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															12.15	11.84	13.84	13.15	13.89

Competitive Comparison of Xtant Medical Holdings's Effective Interest Rate on Debt %

For the Medical Devices subindustry, Xtant Medical Holdings's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xtant Medical Holdings's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Effective Interest Rate on Debt % falls into.

Xtant Medical Holdings Effective Interest Rate on Debt % Calculation

Xtant Medical Holdings's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * -2.694	/	( (16.116	+	21.604)	/ 2 )
=	-1 * -2.694	/	18.86
=	14.28 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	10.233	+	5.883
=	16.116

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	16.545	+	5.059
=	21.604

Xtant Medical Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Sep. 2023 )	+	Total Debt (Q: Dec. 2023 ))	/ count )
=	-1 * -3	/	( (21.579	+	21.604)	/ 2 )
=	-1 * -3	/	21.5915
=	13.89 %

where

	Total Debt (Q: Sep. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	14.431	+	7.148
=	21.579

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	16.545	+	5.059
=	21.604

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Xtant Medical Holdings (FRA:XMS) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Xtant Medical Holdings Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Xtant Medical Holdings (FRA:XMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (FRA:XMS) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

XTNT:USA

Address

664 Cruiser Lane, Belgrade, MT, USA, 59714

Website

http://www.xtantmedical.com

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (FRA:XMS) Headlines

No Headlines